At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
KVUE Kenvue Inc
Post-Mkt 09-17 19:03:25 EDT
17.87
+0.04
+0.22%
盘后17.87
+0.000.00%
18:43 EDT
High18.10Low17.78Vol23.45M
Open17.98D1 Closing17.83Amplitude1.79%
Mkt Cap34.24BTradable Cap33.82BTotal Shares1.92B
T/O419.17MT/O Rate1.24%Tradable Shares1.89B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Canaccord Genuity Keeps Their Buy Rating on Kenvue, Inc. (KVUE)
TIPRANKS  ·  09-17 20:35
Canaccord Genuity Keeps Their Buy Rating on Kenvue, Inc. (KVUE)
Pharma Sector Doubles Down on AI to Slash Costs, Timelines
Reuters  ·  09-16 21:53
Pharma Sector Doubles Down on AI to Slash Costs, Timelines
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid AI Pullback
MT Newswires Live  ·  09-14
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid AI Pullback
EU Antitrust Regulators to Inform Kimberly-Clark This Week About Competition Concerns About Deal, Sources Say
THOMSON REUTERS  ·  09-14
EU Antitrust Regulators to Inform Kimberly-Clark This Week About Competition Concerns About Deal, Sources Say
Kimberly-Clark Readies EU Remedies in Bid for Kenvue Deal, Sources Say
Reuters  ·  09-14
Kimberly-Clark Readies EU Remedies in Bid for Kenvue Deal, Sources Say
Exclusive-Kimberly-Clark May Offer Concessions During EU Regulators' Preliminary Review in Bid to Secure Early Approval, Sources Say
THOMSON REUTERS  ·  09-14
Exclusive-Kimberly-Clark May Offer Concessions During EU Regulators' Preliminary Review in Bid to Secure Early Approval, Sources Say
Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link
Reuters  ·  09-12
Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link
Kenvue Keeps Quarterly Dividend to $0.21 a Share; Payable Oct. 2 to Holders of Record Sept. 21
MT Newswires Live  ·  09-10
Kenvue Keeps Quarterly Dividend to $0.21 a Share; Payable Oct. 2 to Holders of Record Sept. 21
Kenvue Declares Quarterly Dividend of $0.21 Per Share
Reuters  ·  09-10
Kenvue Declares Quarterly Dividend of $0.21 Per Share
Kenvue - Declares Qtrly Cash Dividend of $0.21 Per Share
THOMSON REUTERS  ·  09-10
Kenvue - Declares Qtrly Cash Dividend of $0.21 Per Share
Kenvue Shares Down 1.9%; Study Links Tylenol Use in Pregnancy to Uterus, Ovary Changes in Daughters
THOMSON REUTERS  ·  09-09
Kenvue Shares Down 1.9%; Study Links Tylenol Use in Pregnancy to Uterus, Ovary Changes in Daughters
Kenvue Inc. Stock Falls Tuesday, Underperforms Market
Dow Jones  ·  09-09
Kenvue Inc. Stock Falls Tuesday, Underperforms Market
Kenvue Inc. Stock Falls Friday, Underperforms Market
Dow Jones  ·  09-05
Kenvue Inc. Stock Falls Friday, Underperforms Market
Kenvue Inc. Stock Rises Wednesday, Outperforms Market
Dow Jones  ·  09-03
Kenvue Inc. Stock Rises Wednesday, Outperforms Market
Accc - Without Divestiture of Carefree & Stayfree Brands, Acquisition to Substantially Lessen Competition in Period Care Products' Supply in Australia
THOMSON REUTERS  ·  09-02
Accc - Without Divestiture of Carefree & Stayfree Brands, Acquisition to Substantially Lessen Competition in Period Care Products' Supply in Australia
Australia's Accc - Kimberly-Clark’s Acquisition of Kenvue Approved Subject to Sale of Carefree and Stayfree Brands
THOMSON REUTERS  ·  09-02
Australia's Accc - Kimberly-Clark’s Acquisition of Kenvue Approved Subject to Sale of Carefree and Stayfree Brands
Kenvue Inc. Stock Falls Monday, Underperforms Market
Dow Jones  ·  09-01
Kenvue Inc. Stock Falls Monday, Underperforms Market
Deals of the Day-Mergers and Acquisitions
Reuters  ·  08-28
Deals of the Day-Mergers and Acquisitions
Kimberly-Clark Files for EU Antitrust Approval of Kenvue Takeover
MT Newswires Live  ·  08-28
Kimberly-Clark Files for EU Antitrust Approval of Kenvue Takeover
Kenvue Says Kenvue Cares Week Volunteer Program Logs 7,750 Hours in 2026 Healthy Lives Mission Report
Reuters  ·  08-26
Kenvue Says Kenvue Cares Week Volunteer Program Logs 7,750 Hours in 2026 Healthy Lives Mission Report

Introduction

Company Name.
Kenvue Inc
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Issue price:
--